Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders.
Senior Director, US Brand Strategy & Launch will lead the end-to-end U.S. commercialization strategy for Neurocrine’s upcoming launch in Mood Disorders, with accountability for Healthcare Professional (HCP), some patient marketing strategy, launch execution, and long-term brand performance.
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders.
Regeneron